KI Polyomavirus (KIPyV) is a small non‑enveloped DNA virus in the family Polyomaviridae. It was discovered in 2007 in stored human respiratory samples at the Karolinska Institute and is classified as Betapolyomavirus tertihominis.
Background and Characteristics
Discovered in 2007, KI Polyomavirus was the third human polyomavirus identified and the first new member since BK and JC viruses were described in 1971. It was found in respiratory secretions collected during a study of novel viruses and named for the Karolinska Institute. KIPyV is a small non‑enveloped virus with an icosahedral capsid about 45 nm in diameter and a circular double‑stranded DNA genome of roughly 5,040 base pairs. The genome encodes the major capsid proteins VP1, VP2 and VP3, as well as regulatory proteins large T antigen and small T antigen. These antigens interact with host replication factors to drive viral replication and modulate cell signalling. Sequence analysis places KIPyV in the genus Betapolyomavirus alongside BK, JC and WU polyomaviruses. Infection appears widespread; PCR studies detect viral DNA in about 1–5 % of respiratory samples, while serological surveys report antibodies in more than half of adults, indicating that exposure typically occurs in childhood. Maternal antibodies may pass to infants, and seroprevalence increases with age. To date KIPyV has not been clearly linked to any disease. It is often detected alongside other respiratory viruses, so causality cannot be assigned. Unlike oncogenic polyomaviruses such as the Merkel cell polyomavirus, KIPyV has no known tumourigenic potential. Limited evidence suggests that viral replication may be enhanced in immunocompromised individuals.
Notable Findings and Epidemiology
Studies have found KIPyV DNA in nasopharyngeal swabs from children with respiratory infections, but it is also detected in healthy individuals. Serological surveys from the United States have reported seroprevalence of 55–70 % in adults. The virus shares high genetic similarity with WU Polyomavirus, and both were reported in 2007. Genomic analysis shows that its regulatory region resembles other polyomaviruses, and the major capsid proteins are conserved. Because KIPyV is non‑enveloped, it is resilient in the environment and can persist on surfaces. Routine diagnostic testing is not available, and detection relies on PCR amplification of viral DNA. Most infected individuals mount antibodies against the VP1 protein, indicating effective immune recognition. There is no vaccine or antiviral therapy, reflecting the lack of clinical disease associations. Research continues to clarify whether the virus contributes to respiratory pathology in vulnerable populations. KI Polyomavirus remains an obscure member of the human virome. Its discovery expanded the known diversity of human polyomaviruses and highlighted the breadth of asymptomatic viral carriage. Ongoing surveillance and molecular studies will determine whether this ubiquitous virus has any clinical significance. Related Terms: WU Polyomavirus, BK Virus, JC Virus, Merkel Cell Polyomavirus, Betapolyomavirus